AMANDA AYERS: Open Payments
NPI 1982161782 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 45 payments from 10 companies in 2025. Trend: 2023 $2,493 · 2024 $2,145 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $160 |
| ABBVIE INC. | 9 | $145 |
| Janssen Biotech, Inc. | 5 | $138 |
| UCB, Inc. | 3 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| ANI Pharmaceuticals, Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
Products named: TREMFYA, Bimzelx, RINVOQ, PURIFIED CORTROPHIN GEL, SKYRIZI, OTEZLA, ILARIS, BENLYSTA.
Industry payments across VA — which companies pay providers there.
